Alectinib M1b Metabolite

Status: In-stock

Alectinib M1b Metabolite is a minor metabolite of Alectinib that is a small-molecule ALK inhibitor utilized in the treatment of patients suffering from ALK-positive unresectable, recurrent/advanced Non-small cell lung cancer.

Request quotation

Additional information on Alectinib M1b Metabolite

Catalogue No. VL5710007
Molecular Formula C₃₀H₃₄N₄O₄
Molecular Weight 514.62 g/mol
Parent drug Alectinib
IUPAC Name 2-((1-(3-cyano-9-ethyl-6, 6-dimethyl-11-oxo-6, 11-dihydro-5H-benzo[b]carbazol-8-yl)piperidin-4-yl)(2-hydroxyethyl)amino)acetic acid
Synonyms N/A
References Sato-Nakai, Mika, et al. “Metabolites of Alectinib in Human: Their Identification and Pharmacological Activity.” Heliyon, vol. 3, no. 7, July 2017, p. e00354,
Status In-stock

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

Alectinib M1b Metabolite

"*" indicates required fields

Products quotation
This field is for validation purposes and should be left unchanged.